Effects of 8-OH-DPAT on hippocampal NADH fluorescence in vivo in anaesthetized rats

Journal of Neuroscience Research

Volumn 83, Issue 4, 2006, Pages 551-556

  Rex, Andre ^a   Fink, H ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

5 HT1A agonist; Hippocampus; Mitochondrial activity; Neuronal activity; Serotonin

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; POSTSYNAPTIC RECEPTOR; PRESYNAPTIC RECEPTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SEROTONIN;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; ENERGY TRANSFER; FLUORESCENCE; FLUORESCENCE MICROSCOPY; HIPPOCAMPUS; IN VIVO STUDY; MALE; MITOCHONDRION; NERVE CELL; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANESTHESIA; ANIMALS; HIPPOCAMPUS; LASERS; MALE; NAD; NEURONS; PHOTIC STIMULATION; PIPERAZINES; PYRIDINES; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SPECTROMETRY, FLUORESCENCE;

EID: 33644900719     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.20761     Document Type: Article

References (48)

1. Aghajanian GK, Sanders-Bush E. 2002. Serotonin. In: Davis KL, Charney D, Coyle JT, Nemeroff C, editors. Neuropsychopharmacology. The fifth generation of progress. Philadelphia: Lippincott Williams & Wilkins. p 15-34.
2. Ames A. 2000. CNS energy metabolism as related to function. Brain Res Rev 34:42-68.
3. Astrup J, Sorensen PM, Sorensen HR. 1981. Oxygen and glucose consumption related to Na+-K4+ transport in canine brain. Stroke 12:726-730.
4. Bandelow B, Zohar J, Hollander E, Kasper S, Moller HJ. 2002. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders. World J Biol Psychiatry 3:171-199.
5. Bast T, Feldon J. 2003. Hippocampal modulation of sensorimotor processes. Prog Neurobiol 70:319-345.
6. Blier P, de Montigny C. 1990. Differential effect of gepirone on presynaptic and postsynaptic serotonin receptors: single-cell recording studies. J Clin Psychopharmacol 10(Suppl):13S-20S.
7. Cheng LL, Wang SJ, Gean PW. 1998. Serotonin depresses excitatory synaptic transmission and depolarization-evoked Ca2+ influx in rat basolateral amygdala via 5-HT1A receptors. Eur J Neurosci 10:2163-2172.
8. 1A receptor agonists: Recent developments and controversial issues. Psychopharmacology 121:1-26.
9. Dora E, Gyulai L, Kovach AG. 1984. Determinants of brain activation-induced cortical NAD/NADH responses in vivo. Brain Res 299:61-72.
10. Fletcher A, Forster EA, Bill DJ, Brown G, Cliffe IA, Hartley JE, Jones DE, McLenachan A, Stanhope KJ, Critchley DJ, Childs KJ, Middlefell VC, Lanfumey L, Corradetti R, Laporte AM, Gozlan H, Hamon M, Dourish CT. 1996. Electrophysiological, biochemical, neurohormonal and behavioral studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav Brain Res 73:337-353.
11. Griebel G. 1995. 5-hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacol Ther 65:319-395.
12. Gurevich N, Wu PH, Carlen PL. 1990. Serotonin agonist and antagonist actions in hippocampal CA1 neurons. Can J Physiol Pharmacol 68:586-595.
13. Hajos M, Hajos-Korcsok E, Sharp T. 1999. Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat. Br J Pharmacol 126:1741-1750.
14. Hall MD, el Mestikawy S, Emerit MB, Pichat L, Hamon M, Gozlan H. 1985. [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain. J Neurochem 44:1685-1696.
15. Harbig K, Chance B, Kovach AG, Reivich M. 1976. In vivo measurement of pyridine nucleotide fluorescence from cat brain cortex. J Appl Physiol 41:480-488.
16. Hedlund PB, Sutcliffe JG. 2004. Functional, molecular and pharmacological advances in 5-HT7 receptor research. Trends Pharmacol Sci 25:481-486.
17. Heym J, Steinfels GF, Jacobs BL. 1984. Chloral hydrate anesthesia alters the responsiveness of central serotonergic neurons in the cat. Brain Res 291:63-72.
18. Horrigan DJ, Horwitz BA, Horowitz JM. 1997. Serotonergic modulation of hippocampal pyramidal cells in euthermic, cold-acclimated, and hibernating hamsters. Am J Physiol 273:1291-1298.
19. Ince C, Cremans JMCC, Bruining HA. 1992. In vivo NADH fluorescence. Adv Exp Med Biol 317:277-296.
20. Jolas T, Schreiber R, Laporte AM, Chastanet M, De Vry J, Glaser T, Adrien J, Hamon M. 1995. Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat? J Pharmacol Exp Ther 272:920-929.
21. Kann O, Schuchmann S, Buchheim K, Heinemann U. 2003. Coupling of neuronal activity and mitochondrial metabolism as revealed by NAD(P)H fluorescence signals in organotypic hippocampal slice cultures of the rat. Neuroscience 119:87-100.
22. Kasischke KA, Vishwasrao HD, Fisher PJ, Zipfel WR, Webb WW. 2004. Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis. Science 305:99-103.
23. Katsurabayashi S, Kubota H, Tokutomi N, Akaike N. 2003. A distinct distribution of functional presynaptic 5-HT receptor subtypes on GABAergic nerve terminals projecting to single hippocampal CA1 pyramidal neurons. Neuropharmacology 44:1022-1030.
24. LaManna JC, Sylvia AL, Martel D, Rosenthal M. 1976. Fluorometric monitoring of the effects of adrenergic agents on oxidative metabolism in intact cerebral cortex. Neuropharmacology 15:17-24.
25. LaManna JC, Cordingley G, Rosenthal M. 1977. Phenobarbital actions in vivo: effects on extra cellular potassium activity and oxidative metabolism in cat cerebral cortex. J Pharmacol Exp Ther 200:560-569.
26. Mayevsky A. 1984. Brain NADH redox state monitored in vivo by fiber optic surface fluorometry. Brain Res 319:49-68.
27. Mengod G, Vilaro M, Raurich A, Lopezgimenez J, Cortes R, Palacios J. 1996. 5-HT receptors in mammalian brain. Receptor autoradiography and in situ hybridization studies of new ligands and newly identified receptors. Histochem J 28:747-758.
28. Mottin S, Laporte P, Jouvet M, Cespuglio R. 1997. Determination of NADH in the rat brain during sleep-wake states with an optic fibre sensor and time-resolved fluorescence procedures. Neuroscience 79: 683-693.
29. 1A antagonists WAY100135 and SDZ 216-525 on 5-HT neuronal firing in the guinea-pig dorsal raphe nucleus. Neuropharmacology 33:61-66.
30. Nutt DJ. 2005. Overview of diagnosis and drug treatments of anxiety disorders. CNS Spectr 10:49-56.
31. Paxinos G, Watson C. 1998. The rat brain in stereotaxic coordinates. Academic Press: New York.
32. 1A Receptors and changes in extracellular 5-HT in the guinea-pig prefrontal cortex: Involvement in aversive behavior. J Psychopharmacol 7:338-345.
33. Rex A, Pfeifer L, Fink F, Fink H. 1999. Cortical NADH during pharmacological manipulations of the respiratory chain and spreading depression in vivo. J Neurosci Res 57:359-370.
34. Rex A, Hentschke MP, Fink H. 2002. Bioavailability of reduced nicotinamide-adenine-dinucleotide (NADH) in the central nervous system of the anaesthetized rat measured by laser-induced fluorescence spectroscopy. Pharmacol Toxicol 90:220-225.
35. Schmitz D, Empson RM, Heinemann U. 1995. Serotonin and 8-OH-DPAT reduce excitatory transmission in rat hippocampal area CA1 via reduction in presumed presynaptic Ca2+ entry. Brain Res 701:249-254.
36. 1A receptor agonists on 5-HT release in rat brain in vivo. Naunyn-Schmiedebergs Arch Pharmacol 348:339-346.
37. Shuttleworth CW, Brennan AM, Connor JA. 2003. NAD(P)H fluorescence imaging of postsynaptic neuronal activation in murine hippocampal slices. J Neurosci 23:3196-3208.
38. Sibson NR, Dhankhar A, Mason GF, Rothman DL, Behar KL, Shulman RG. 1998. Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proc Natl Acad Sci USA 95:316-321.
39. Sprouse JS, Aghajanian GK. 1988. Response of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons. Neuropharmacology 27:707-715.
40. Stahl SM. 1998. The serotonin selective reuptake inhibitors. In: Stahl SM, editor. Psychopharmacology of antidepressants. London: Martin Dunitz. p 39-60.
41. 1A agonists suppress firing activity of dorsal hippocampus CA1 pyramidal neurons through a postsynaptic mechanism: single-unit study in unanesthetized, unrestrained rats. J Pharmacol Exp Ther 288:843-848.
42. Tanaka E, North RA. 1993. Actions of 5-hydroxytryptamine on neurons of the rat cingulate cortex. J Neurophysiol 69:1749-1757.
43. Thomas DR, Hagan JJ. 2004. 5-HT7 receptors. Curr Drug Targets CNS Neurol Disord 3:81-90.
44. Tokarski K, Zahorodna A, Bobula B, Hess G. 2002. Comparison of the effects of 5-HT1A and 5-HT4 receptor activation on field potentials and epileptiform activity in rat hippocampus. Exp Brain Res 147: 505-510.
45. Voigt JP, Rex A, Sohr R, Fink H. 1999. Hippocampal 5-HT and NE release in the transgenic rat TGR(mREN2)27 related to behavior on the elevated plus maze. Eur Neuropsychopharmacol 9:279-285.
46. Wesolowska A, Borycz J, Paluchowska MH, Chojnacka-Wojcik E. 2002. Pharmacological analysis of the hypothermic effects of NAN-190 and its analogs, postsynaptic 5-HT1A receptor antagonists, in mice. Pol J Pharmacol 54:391-399.
47. Yoshitake T, Kehr J. 2004. Differential effects of (R)-, (R, S)- and (S)-8-hydroxy-2-(di-n-propylamino)tetralin on hippocampal serotonin release and induction of hypothermia in awake rats. Life Sci 74:2865-2875.
48. Yu H, Lewander T. 1997. Pharmacokinetic and pharmacodynamic studies of (R)-8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Eur Neuropsychopharmacol 7:165-172.